Ionis Pharmaceuticals market cap IONS
Share price times shares outstanding: what the whole company sells for, since 2010.
- Today, Nov 2, 2026
- $6.9B
- Highest close in our data
- $14B
- Feb 2026
Ionis Pharmaceuticals is worth $6.9B at the close on Nov 2, 2026, at $41.24 a share.
That is down 42% over the last year and up 44% over five years.
Its highest close in our data was $14B in Feb 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $6.9B | $6.9B | $14B | −47% |
| 2025 | $12.9B | $4.3B | $13.4B | +128% |
| 2024 | $5.7B | $5.4B | $7.7B | −22% |
| 2023 | $7.3B | $4.9B | $7.4B | +35% |
| 2022 | $5.4B | $4.2B | $6.6B | +25% |
| 2021 | $4.3B | $3.7B | $8.6B | −46% |
| 2020 | $7.9B | $6.1B | $8.8B | −8% |
| 2019 | $8.5B | $7.5B | $11.8B | +21% |
| 2018 | $7.1B | $5.1B | $8B | +13% |
| 2017 | $6.3B | $4.8B | $8B | +8% |
| 2016 | $5.8B | $2.6B | $6.8B | −22% |
| 2015 | $7.4B | $5.2B | $8.8B | −1% |
| 2014 | $7.5B | $2.8B | $7.7B | +61% |
| 2013 | $4.7B | $1.1B | $4.8B | +356% |
| 2012 | $1B | $725M | $1.5B | +42% |
| 2011 | $719M | $645.2M | $1B | −28% |
| 2010 | $1B | $788.5M | $1B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Ionis Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| IONSIonis Pharmaceuticals | $6.9B |
| KNSAKiniksa Pharmaceuticals International | $7.1B |
| AMRXAmneal Pharmaceuticals | $6.5B |
| ALKSAlkermes plc. | $7.5B |
| LGNDLigand Pharmaceuticals | $6.1B |
| CORTCorcept Therapeutics | $8.7B |
| PTGXProtagonist Therapeutics | $9B |
| TGTXTG Therapeutics | $9.2B |
| INDVIndivior Pharmaceuticals | $4.3B |
| BMRNBiomarin Pharmaceutical | $11.1B |
| ARQTArcutis Biotherapeutics | $3.9B |
| Peer median | $7.3B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Ionis Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.